AU2003237763A1 - Cationic lipids for intracellular delivery of bioactive substances - Google Patents
Cationic lipids for intracellular delivery of bioactive substancesInfo
- Publication number
- AU2003237763A1 AU2003237763A1 AU2003237763A AU2003237763A AU2003237763A1 AU 2003237763 A1 AU2003237763 A1 AU 2003237763A1 AU 2003237763 A AU2003237763 A AU 2003237763A AU 2003237763 A AU2003237763 A AU 2003237763A AU 2003237763 A1 AU2003237763 A1 AU 2003237763A1
- Authority
- AU
- Australia
- Prior art keywords
- cationic lipids
- intracellular delivery
- bioactive substances
- bioactive
- substances
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
- A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37954902P | 2002-05-10 | 2002-05-10 | |
US60/379,549 | 2002-05-10 | ||
PCT/SG2003/000109 WO2003094971A1 (fr) | 2002-05-10 | 2003-05-10 | Lipides cationiques pour la liberation intracellulaire de substances bioactives |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003237763A1 true AU2003237763A1 (en) | 2003-11-11 |
Family
ID=29420536
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003237763A Abandoned AU2003237763A1 (en) | 2002-05-10 | 2003-05-10 | Cationic lipids for intracellular delivery of bioactive substances |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003237763A1 (fr) |
WO (1) | WO2003094971A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8821859B2 (en) * | 2004-05-19 | 2014-09-02 | Agency For Science, Technology And Research | Methods and articles for the delivery of therapeutic agents |
WO2013116126A1 (fr) * | 2012-02-01 | 2013-08-08 | Merck Sharp & Dohme Corp. | Nouveaux lipides cationiques biodégradables de faible masse moléculaire pour la délivrance d'oligonucléotides |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4391637A (en) * | 1981-10-19 | 1983-07-05 | Nl Industries, Inc. | Rheological additive for non-aqueous fluid systems |
JPH085996B2 (ja) * | 1987-07-02 | 1996-01-24 | 株式会社ボロンインターナショナル | 導電フィルムの製造法 |
JPH0995471A (ja) * | 1995-10-02 | 1997-04-08 | Boron Internatl:Kk | カチオン化合物 |
WO2001091725A2 (fr) * | 2000-05-31 | 2001-12-06 | Univ Johns Hopkins | Polyphosphates presentant une utilite biologique |
-
2003
- 2003-05-10 AU AU2003237763A patent/AU2003237763A1/en not_active Abandoned
- 2003-05-10 WO PCT/SG2003/000109 patent/WO2003094971A1/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003094971A1 (fr) | 2003-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2102101A (en) | Use of cationic lipids for intracellular protein delivery | |
AU2003281752A1 (en) | Medicament dispenser | |
AU2003254590A1 (en) | Medicament dispenser | |
AU2003246734A1 (en) | Medicament dispenser | |
AU2003246722A1 (en) | Medicament dispenser | |
AU2003250166A1 (en) | Medicament dispenser | |
IL164031A (en) | Compositiion having gelling properaties for the prolonged delivery of bioactive substances | |
AU2003222137A1 (en) | Microgel particles for the delivery of bioactive materials | |
AU2002242883A1 (en) | Medicament dispenser | |
AU2002251238A1 (en) | Medicament dispenser | |
AU2002358805A1 (en) | Medicament dispenser | |
EP1545662B8 (fr) | Systeme d'administration de medicament | |
AU2003299849A1 (en) | Drug delivery apparatus | |
AU4357800A (en) | Intracellular pharmaceutical targeting | |
AU2003268087A1 (en) | Liposomal gemcitabine compositions for better drug delivery | |
AU2002330886A1 (en) | Novel targeted delivery system for bioactive agents | |
AU3900299A (en) | Cationic lipids with disulphide bonds for the intracellular delivery of therapeutic substances | |
AU2003222067A1 (en) | System for delivery of therapeutic substances | |
AU2003229738A1 (en) | Medicament dispenser | |
AU2003211103A1 (en) | Intracellular delivery of therapeutic agents | |
AU2003255398A1 (en) | Lipid preparation, particularly cosmetic preparation | |
AU6887401A (en) | Delivery of remotely-ordered products | |
AU2002330692A1 (en) | Delivery of a bioactive material | |
AU2003301444A1 (en) | System for delivery of active substances | |
AU2002348971A1 (en) | Ph-sensitive liposomes for targeted drug delivery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase | ||
TH | Corrigenda |
Free format text: IN VOL 18, NO 2, PAGE(S) 532 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME JOHNS HOPKINS SINGAPORE PTE LTD, APPLICATION NO. 2003237763, UNDER INID (43) CORRECT THE PUBLICATION DATE TO READ 24.11.2003 |